Gapicomine

From Wikipedia, the free encyclopedia
Gapicomine
Systematic (IUPAC) name
1-Pyridin-4-yl-N-(pyridin-4-ylmethyl)methanamine
Clinical data
Legal status off market (was used in EU countries)
Routes oral (tablet)
Identifiers
CAS number 1539-39-5 YesY
ATC code None
PubChem CID 68955
ChemSpider 62178 N
UNII WWW0P95393 YesY
Chemical data
Formula C12H13N3 
Mol. mass 199.25 g/mol
 N (what is this?)  (verify)

Gapicomine (INN) is a coronary vasodilator. It has been withdrawn from the market in the countries it was used in.[1]

Also, gapicomine is a major component in the drug Bicordin.[2]

History

Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug Bicordin in 1974.[3]

References

  1. "Gapicomine Monograph, The Index Nominum". Retrieved 2008-03-31. 
  2. "Bicordin, PubChem". Retrieved 2008-03-31. 
  3. Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E. (1974). "Bicordin--a new drug in the treatment of coronary heart disease.". Mater Med Pol. 6 (4): 298–300. PMID 4453155. 



This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.